Ariel I M
Pack Medical Foundation, Cabrini Medical Center, New York, New York 10016.
Semin Surg Oncol. 1988;4(1):7-12. doi: 10.1002/ssu.2980040104.
Most nerve tumors (benign and malignant) do not arise from the nerves per se, but from the supporting cells; tumors arising from the cells of Schwann are termed schwannoma or neurilemmoma-benign or malignant. Surgical extirpation is the most effective treatment for these tumors. Radiation therapy can offer significant palliation and prolongation of life, but no cures have been observed. Benign tumors can be treated by local surgical extirpation; malignant tumors must be radically resected, including major amputation where indicated. Neurofibromatosis (von Recklinghausen's disease) is a genetic error of metabolism with a proclivity to produce multiple neurofibromas and, in about 10% of the patients, malignant neurilemmomas. Of 100 patients with malignant neurilemmomas treated by the author, 74 were considered determinate; among them, the 10-year "cure" rate was 32%. Patients with von Recklinghausen's disease had almost as good a 10-year survival rate as those with solitary malignant schwannoma (30% vs. 39%).
大多数神经肿瘤(良性和恶性)并非起源于神经本身,而是起源于支持细胞;起源于施万细胞的肿瘤被称为神经鞘瘤或神经膜瘤——良性或恶性。手术切除是这些肿瘤最有效的治疗方法。放射治疗可提供显著的姑息治疗并延长生命,但尚未观察到治愈病例。良性肿瘤可通过局部手术切除进行治疗;恶性肿瘤必须进行根治性切除,必要时包括大截肢。神经纤维瘤病(冯·雷克林豪森病)是一种代谢遗传缺陷病,易产生多发性神经纤维瘤,约10%的患者会发生恶性神经鞘瘤。在作者治疗的100例恶性神经鞘瘤患者中,74例被认为是确诊病例;其中,10年“治愈”率为32%。冯·雷克林豪森病患者的10年生存率与孤立性恶性神经鞘瘤患者几乎相同(30%对39%)。